45 completed, 11 terminated, 9 active not recruiting, 9 recruiting. 22 Not applicable, 6 Phase 2, 3 Phase 3, 2 Phase 1.
Follow Cytology Specimen Collection Procedure: new trials by email Literature Review of Cytology Specimen Collection Procedure trials Research Report on Cytology Specimen Collection Procedure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Medical Examination - HIV Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors Cytology Specimen Collection Procedure, Diagnostic Laboratory Biomarker Analysis, Medical Chart Review - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Recruiting | Roswell Park Cancer Institute | 700 | 2020-07-03 | 2025-11-13 | |
| Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer Catheter Management, Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Stage II Bladder Urothelial Carcinoma | Withdrawn | University of Southern California | 2018-02-05 | 2018-01-02 | ||
| Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Quality-of-Life Assessment - Recurrent Neuroblastoma, Stage 2A Neuroblastoma | Active not recruiting | Children's Oncology Group | 376 | 2017-06-05 | 2026-01-09 | |
| Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Recurrent Adult Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia | Completed | Wake Forest University Health Sciences | 14 | 2017-04-21 | 2022-10-20 | |
| Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Quality-of-Life Assessment - Barrett Esophagus, Dysplasia | Not applicable | Completed | OHSU Knight Cancer Institute | 11 | 2016-08-03 | 2020-11-25 |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Radical Cystectomy - Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma | Phase 1 | Terminated | University of Southern California | 2 | 2016-08-02 | 2021-11-24 |
| High Definition Single Cell Analysis in Colorectal Cancer Biomarker Analysis, Cytology Specimen Collection Procedure - Metastatic Carcinoma in the Liver, Stage IV Colorectal Cancer | Completed | University of Southern California | 24 | 2016-08-01 | 2023-08-14 | |
| Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Acute Myeloid Leukemia, Febrile Neutropenia | Completed | Stanford University | 56 | 2016-08-01 | 2019-05-16 | |
| Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma | Terminated | University of Southern California | 7 | 2016-06-14 | 2021-04-05 | |
| Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer cytology specimen collection procedure, targeted therapy, therapeutic procedure - Malignant Neoplasm | Not applicable | Completed | Fox Chase Cancer Center | 30 | 2016-03-17 | 2021-02-04 |
| MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - No Evidence of Disease, Stage II Bladder Cancer | Terminated | University of Southern California | 10 | 2016-03-01 | 2022-08-10 | |
| Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Questionnaire Administration - Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Gastrointestinal Stromal Tumor | Withdrawn | University of Southern California | 2016-03-01 | 2024-03-18 | ||
| Project: Every Child for Younger Patients With Cancer Cytology Specimen Collection Procedure, Medical Chart Review - Adrenal Gland Pheochromocytoma, Carcinoma In Situ | Recruiting | Children's Oncology Group | 75000 | 2015-11-03 | 2026-08-25 | |
| High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia Chemosensitivity Assay, Cytology Specimen Collection Procedure, Gene Expression Analysis - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Not applicable | Completed | University of Washington | 34 | 2015-09-11 | 2022-06-30 |
| Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer Computed Tomography, Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Healthy Subject, Metastatic Renal Cell Cancer | Active not recruiting | University of Southern California | 37 | 2015-09-08 | 2026-04-02 | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) Adavosertib, Afatinib, Afatinib Dimaleate - Advanced Lymphoma, Advanced Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 6452 | 2015-08-17 | 2026-10-26 |
| Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Benign Prostatic Hyperplasia, Prostate Carcinoma | Completed | Wake Forest University Health Sciences | 43 | 2015-07-28 | 2021-09-01 | |
| Collection and Storage of Tissue and Blood Samples From Patients With Cancer Cytology Specimen Collection Procedure - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Recruiting | National Cancer Institute LAO | 5000 | 2015-05-19 | 2026-10-22 |
Showing 20 of 88. Sign in to see all of them.
Breast Neoplasms (13) · Neoplasms (8) · Carcinoma, Non-Small-Cell Lung (7) · Papillomavirus Infections (7) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (7) · Prostatic Neoplasms (7) · Uterine Cervical Neoplasms (7) · Leukemia, Myeloid, Acute (6) · Lung Neoplasms (6) · Urinary Bladder Neoplasms (6) · HIV Infections (5) · Lymphoma (5) · Neuroblastoma (5) · Rectal Neoplasms (5) · Carcinoma, Renal Cell (4)
Children's Oncology Group (14) · University of Southern California (12) · National Cancer Institute (NCI) (6) · Fox Chase Cancer Center (5) · AIDS Malignancy Consortium (4) · Jonsson Comprehensive Cancer Center (4) · University of Washington (4) · OHSU Knight Cancer Institute (3) · Royal Marsden NHS Foundation Trust (3) · Wake Forest University Health Sciences (3) · City of Hope Medical Center (2) · Ohio State University Comprehensive Cancer Center (2) · Stanford University (2) · Albert Einstein College of Medicine (1) · Alliance for Clinical Trials in Oncology (1)
United States (76) · Canada (15) · Puerto Rico (13) · Australia (12) · New Zealand (9) · Switzerland (8) · United Kingdom (7) · India (3) · Guam (2) · Netherlands (2) · Saudi Arabia (2) · South Korea (2) · Costa Rica (1) · Ireland (1) · Israel (1)
Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng) (3) · Jacek Pinski, MD (2) · Joel Palefsky (2) · Agnieszka K Witkiewicz (1) · Aimee Kreimer (1) · Amanda M Termuhlen (1) · Andrew Olshan (1) · Ann M Gillenwater (1) · Anna Wu (1) · Anthony Olszanski (1) · Aprille Seidel, PhD (1) · Ashok K Hemal (1) · Barbara Gitlitz (1) · Barbara Gitlitz, MD (1) · Carlos Caldas (1)
PMID 22277551, PMID 26586415, PMID 28332888, PMID 30653209, PMID 31264912, PMID 32267967, PMID 32375690, PMID 32463741, PMID 33048619, PMID 33271093, PMID 35133871, PMID 35138919, PMID 35297944, PMID 35709811, PMID 36351402, PMID 37053535, PMID 37322121, PMID 37704753, PMID 37933882, PMID 37934000, PMID 38396300, PMID 38591867, PMID 38815188, PMID 39666929, PMID 39693587, PMID 39805155, PMID 39913886, PMID 40167440, PMID 40506447, PMID 40608342, PMID 40865033, PMID 41066729, PMID 41100122, PMID 41576303, PMID 42487567, PMID 42657661
P30CA014089 (12), U10CA098543 (12), UG1CA189958 (8), U10CA180886 (5), P30CA006927 (4), P30CA012197 (3), P30CA022453 (2), U01CA121947 (2), U10CA031946 (2), U10CA180821 (2), U10CA180868 (2), UM1CA121947 (2), N01CM62201 (1), P30CA006973 (1), P30CA013330 (1)